Validation psychométrique d’une échelle française d’auto-stigmatisation auprès d’un échantillon de patients souffrant de troubles mentaux : la Self-Stigma Scale-Short (SSS-S)

Golay, Philippe; Martinez, Debora; Silva, Benedetta; Morandi, Stéphane; Bonsack, Charles

doi:10.1016/j.amp.2021.09.002

Cited by 4 publications

(9 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The second goal was to explore potential alternative structures through EFA, followed by CFA. There are discrepancies in the previously observed factorial structure of the SSS-S: a confirmed second-order model in Hong Kong samples (Mak & Cheung, 2010), a one-factor structure in a U.S. sample (Sánchez et al, 2020), and most recently the originally proposed three-factor model in a French sample (Golay et al, 2022). These differences may be due to language, population, setting, or some other unknown factors.…”

mentioning

confidence: 68%

“…Participants rated statements (e.g., “I estrange myself from others because I am a mental health consumer”) on a 4-point Likert-type scale (1 = strongly disagree , 4 = strongly agree ). The coefficient α ranged from .88 to .93 for the total score (Golay et al, 2022; Mak & Cheung, 2010; Sánchez et al, 2020) and from .74 to .89 for the subscale scores (Golay et al, 2022).…”

Section: Methodsmentioning

confidence: 99%

“…Model 1 = one-factor model(Sánchez et al, 2020); Model 2 = two-factor model with correlated first-order domain-specific factors; Model 3 = three-factor model with correlated first-order domain-specific factors(Golay et al, 2022;Mak & Cheung, 2010); Model 5 = bifactor model; CFI = comparative fit index; TLI = Tucker Lewis Index; RMSEA = root mean square error of approximation; SRMR = standardized root mean square residual; AIC = Akaike information criterion; SaBIC = sample-size-adjusted Bayesian information criterion; CI = confidence interval.…”

mentioning

confidence: 99%

“…Confirmatory factor analysis (CFA) of the SSS-S demonstrated both an interrelated three-factor structure and a second-order structure representing the latent factor of self-stigma (Mak & Cheung, 2010). The SSS-S has also been validated with samples of people with psychiatric disabilities in Mandarin Chinese (Wu et al, 2015), Taiwanese (Chang et al, 2018), and French (Golay et al, 2022). International studies of the SSS-S found moderate negative correlations with self-efficacy, self-esteem, and quality of life and low positive association with depression, anxiety, somatic symptoms, and stress (Chang et al, 2018; Fan et al, 2022; Golay et al, 2022; Mak & Cheung, 2010; Wu et al, 2015), providing support of its concurrent validity.…”

mentioning

confidence: 99%

See 3 more Smart Citations

Unidimensional versus multidimensional: A bifactor factor structure of the Self-Stigma Scale–Short (SSS-S) among U.S. adults with psychiatric disabilities.

Pan,

Babb,

Brown

et al. 2024

Psychiatric Rehabilitation Journal

View full text Add to dashboard Cite

Objective: This study aimed to examine the psychometric properties of the English version of the Self-Stigma Scale-Short (SSS-S), a nine-item self-report self-stigma measurement, among U.S. adults with psychiatric disabilities. Method: We obtained reliability and validity evidence from a sample of 275 adults with psychiatric disabilities. Results: Exploratory factor analysis (EFA; n = 139) yielded a two-factor solution that accounts for 64.97% of the variance. Confirmatory factor analysis (CFA; n = 136) was conducted to compare alternative solutions, including a single-factor model, a two-correlated-factor model, a three-correlated-factor model, and a bifactorial model. The CFA results supported the bifactor S•I − 1 model as a superior latent factor structure for the SSS-S. The coefficient ω of the SSS-S was .94, indicating excellent internal reliability. Concurrent validity of the SSS-S was supported by significant positive correlations with societal stigma and psychiatric symptom severity, and negative correlations with psychiatric disability acceptance, general self-efficacy, and hope. Conclusions and Implications for Practice: The overall findings concluded that the English version of the SSS-S demonstrated reliable and valid scores and a primarily unidimensional structure of self-stigma among U.S. adults with psychiatric disabilities. Given the adverse impact of self-stigma and its relationships with recovery-related constructs shown in this study, the routine use of the SSS-S is recommended in psychiatric rehabilitation settings. Impact and ImplicationsThis study evaluated the psychometric properties of the SSS-S in a sample of U.S. adults with psychiatric disabilities. It provided reliability and validity evidence for the SSS-S as a measurement of mental illness self-stigma in U.S. adults with psychiatric disabilities. Therefore, it is in fact suitable for measuring self-stigma in psychiatric rehabilitation settings.

show abstract

mentioning

confidence: 68%

Section: Methodsmentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Unidimensional versus multidimensional: A bifactor factor structure of the Self-Stigma Scale–Short (SSS-S) among U.S. adults with psychiatric disabilities.

Pan,

Babb,

Brown

et al. 2024

Psychiatric Rehabilitation Journal

View full text Add to dashboard Cite

show abstract

“…The WHOQOL assesses self-perceived quality of life considering environment, social relationships, psychological and physical health. This instrument showed high internal consistency and coherent pattern of correlations with other validated psychiatric measures in French language patients in our region (Golay et al, 2019;Golay, Martinez, et al, 2021;Golay, Moga, et al, 2021). If quality of life after 36 months was not available, we used the 30 months value instead.…”

Section: Methodsmentioning

confidence: 99%

The differential impact of duration of untreated psychosis on functioning and quality of life: A threshold analysis

Golay

Ramain

Mebdouhi

et al. 2022

Early Intervention Psych

Self Cite

View full text Add to dashboard Cite

Aim: Reduction of duration of untreated psychosis (DUP) remains a key goal of early intervention programs. While a significant body of literature suggests that a short DUP has a positive impact on outcome, little is known regarding the threshold above which various dimensions of outcome are impaired. In this study, we explore the DUP threshold that best discriminates subgroups with poorer outcome regarding global functioning and quality of life after 3 years of treatment.Method: A total of 432 patients were followed-up prospectively over 3 years. Several hypothetical cut-off points for DUP were tested in order to maximize differences in effect size for quality of life and general functioning.Results: While a DUP cut-off of 86 weeks defined two subpopulations with a difference of greatest effect size in quality of life after 3 years, it is already at a cut-off of 3 weeks of DUP that two subpopulations with a difference in global functioning of the greatest effect size was reached. Conclusion:DUP seems to have a differential impact on the various components of outcome, and in particular on quality of life and global functioning. Our data suggest that aiming at very short DUP is justified, but that DUP over 3 weeks are still compatible with good quality of life after 3 years of treatment.duration of untreated psychosis, early intervention, functioning, quality of life | INTRODUCTIONDelay between psychosis onset and exposure to appropriate treatment or 'duration of untreated psychosis' (DUP), has been identified as a key target in specialized early intervention programs in the early phase of psychotic disorders (Joa et al., 2007;Melle et al., 2008;NHS, 2015). This is based on the assumption that its reduction may have a positive impact on the course of symptoms and functioning (Melle et al., 2008).Several papers have shown DUP to be significantly associated with outcomes: these studies reported lower severity of symptoms, better functioning and quality of life, as well as higher remission rates in patients with shorter DUP (

show abstract

Are the self-stigma and perceived stigma of patients treated with methadone or buprenorphine still a problem fifty years after the marketing authorization for opioid agonist treatment? The observational STIGMA study

Pinhal,

Schreck,

Leboucher

et al. 2024

Addict Sci Clin Pract

View full text Add to dashboard Cite

Background In the context of the opioid overdose crisis, understanding the barriers to seeking, attaining and remaining in treatment for patients with opioid use disorder (OUD) is a public health issue. To date, very few studies have assessed the “self-stigma” (i.e., the internalization of negative societal attitudes and stereotypes about oneself, leading to self-judgment) and “perceived stigma” (i.e., the belief that others hold negative attitudes towards oneself due to a particular condition) experienced by patients with OUD receiving opioid agonist treatment (OAT), and none have done so in France. Our study aimed to quantify self-stigma, explore some aspects of perceived stigma, determine the factors associated with greater self-stigma and examine whether the level of self-stigma was related to a delay in seeking care. Methods The STIGMA study was a monocentric, cross-sectional study. The data were collected in a French hospital addiction medicine department. Participants were outpatients with current or past OUD who were still receiving or had received OAT. A questionnaire assessing sociodemographics; OUD characteristics; perceived stigma; and quantification of self-stigma by the Self-Stigma Scale-Short, was administered. Results A total of 73 questionnaires were included in the analysis. Nearly two-thirds of the patients had a “moderate to high” level of self-stigma. These patients were significantly younger at OUD onset and were significantly more likely to have at least one dependent child than patients reporting a “very low to low” level of self-stigma. Nearly half of the participants experienced perceived stigma from a healthcare professional regarding their OUD or OAT, and nearly one-third of the participants were refused care from a healthcare professional because of their OUD or OAT. Moreover, a quarter of the sample reported delaying care due to fear of being stigmatized. We did not find a relationship between self-stigma levels and a delay in seeking care. Conclusions Our study highlights the need to detect stigma and to improve training in addiction medicine.

show abstract

Validation psychométrique d’une échelle française d’auto-stigmatisation auprès d’un échantillon de patients souffrant de troubles mentaux : la Self-Stigma Scale-Short (SSS-S)

Cited by 4 publications

References 17 publications

Unidimensional versus multidimensional: A bifactor factor structure of the Self-Stigma Scale–Short (SSS-S) among U.S. adults with psychiatric disabilities.

Unidimensional versus multidimensional: A bifactor factor structure of the Self-Stigma Scale–Short (SSS-S) among U.S. adults with psychiatric disabilities.

The differential impact of duration of untreated psychosis on functioning and quality of life: A threshold analysis

Are the self-stigma and perceived stigma of patients treated with methadone or buprenorphine still a problem fifty years after the marketing authorization for opioid agonist treatment? The observational STIGMA study

Contact Info

Product

Resources

About